- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lung Cancer (NSCLC)
Total 96201 results
-
Ethicon Endo-SurgeryCompleted
-
PfizerWithdrawnAdvanced EGFRm (Del 19 or L858R +/- T790M) NSCLC
-
The Netherlands Cancer InstituteNot yet recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Peter MacCallum Cancer Centre, AustraliaRecruiting
-
University Hospital, MontpellierRecruiting
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting
-
Radboud University Medical CenterDutch Society of Physicians for Pulmonology and TuberculosisRecruiting
-
Lung Cancer Mutation ConsortiumLung Cancer Research FoundationRecruiting
-
Addario Lung Cancer Medical InstituteUniversity of Southern California; Ohio State University Comprehensive Cancer...Recruiting
-
Guangdong Association of Clinical TrialsRecruiting
-
EQRx International, Inc.Terminated
-
The First Affiliated Hospital of Zhengzhou UniversityActive, not recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Yonsei UniversityCompleted
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
University Hospital, EssenRecruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Active, not recruiting
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Shenzhen People's HospitalEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Kiang Wu HospitalCompleted
-
Agenus Inc.Terminated
-
AstraZenecaUnknownNSCLC Patient CharacteristicsSaudi Arabia
-
National Cancer Center, KoreaPfizer; Roche Pharma AGUnknownNSCLC | Lung CancerKorea, Republic of
-
AstraZenecaRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Eckhard PodackWithdrawnNon-Small Cell Lung Cancer | NSCLC | Lung Cancer | Non-small-cell Lung Carcinoma
-
University Health Network, TorontoOICRNot yet recruitingNon-Small Cell Lung Cancer (NSCLC) | Clinical Staging T2b-3 N0-1 M0
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedUnresectable or Metastatic Non-small Cell Lung Cancer (NSCLC)United States
-
AIO-Studien-gGmbHAstraZenecaRecruitingNSCLC | EGFR Positive Non-small Cell Lung Cancer | OligoprogressionGermany
-
National Taiwan University HospitalUnknownNon-small Cell Lung Cancer(NSCLC)Taiwan
-
Tiziana Life Sciences LTDNot yet recruiting
-
AkesoRecruiting
-
Shanghai Chest HospitalNot yet recruiting
-
Allist Pharmaceuticals, Inc.Recruiting
-
Olfred HansenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruiting
-
Xinqiao Hospital of ChongqingCompleted
-
InventisBio Co., LtdActive, not recruiting
-
Allist Pharmaceuticals, Inc.Withdrawn
-
Klinikum Bayreuth GmbHPeking University Cancer Hospital & Institute; Sana Klinikum HofCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Weston Park Hospital Cancer Charity; Sheffield Hospitals...Completed